One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Flashback Foreword: Multigene Predictor for Chemotherapy Response in Breast Cancer.
Wolff, Antonio C. MD, FACP, FASCO 1,2,,
doi : 10.1200/JCO.23.00243
Volume 41(20) pgs. 3563-3659 July 10, 2023
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor-Positive Breast Cancer.
Paik, Soonmyung; Tang, Gong; Shak, Steven; Kim, Chungyeul; Baker, Joffre; Kim, Wanseop; Cronin, Maureen; Baehner, Frederick L.; Watson, Drew; Bryant, John; Costantino, Joseph P.; Geyer, Charles E. Jr; Wickerham, D. Lawrence; Wolmark, Norman
doi : 10.1200/JCO.22.02570
The Past, Present, and Future of Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer.
McManus, Hannah D. MD 1,; Armstrong, Andrew J. MD, ScM 1,
doi : 10.1200/JCO.23.00323
Quality Surgical Care and Outcomes for Patients With Non-Small-Cell Lung Cancer.
Kehl, Kenneth L. MD, MPH 1,2,3,,; Jaklitsch, Michael T. MD 2,3
doi : 10.1200/JCO.23.00745
Early Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer.
Wala, Jeremiah MD, PhD 1,; Nguyen, Paul MD, MBA 1,; Pomerantz, Mark MD 1,,
doi : 10.1200/JCO.23.00723
Why Good Cancer Care Means Gender-Affirming Care for Transgender Individuals With Gendered Cancers: Implications for Research, Policy, and Practice.
Bybee, Sara G. PhD, LCSW 1,; Wilson, Christina M. PhD, CRNP, WHNP-BC 2
doi : 10.1200/JCO.22.01857
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial.
Hussain, Maha MD 1,; Tombal, Bertrand MD, PhD 2,; Saad, Fred MD 3,; Fizazi, Karim MD, PhD 4,; Sternberg, Cora N. MD 5,; Crawford, E. David MD 6,; Shore, Neal MD 7,; Kopyltsov, Evgeny MD 8; Kalebasty, Arash Rezazadeh MD 9,; Bogemann, Martin MD 10,; Ye, Dingwei MD 11; Cruz, Felipe MD, PhD 12,; Suzuki, Hiroyoshi MD, PhD 13,; Kapur, Shivani MD 14,; Srinivasan, Shankar PhD 15,; Verholen, Frank MD 16,; Kuss, Iris MD 17,; Joensuu, Heikki MD 18,; Smith, Matthew R. MD, PhD 19,
doi : 10.1200/JCO.23.00041
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16).
Gillessen, Silke MD 1,2,; Procopio, Giuseppe MD 3,; Hayoz, Stefanie PhD 4; Kremer, Eloise MD 4; Schwitter, Michael MD 5; Caffo, Orazio MD 6,; Lorente, David PhD 7,; Pedrazzini, Augusto MD 8; Roubaud, Guilhem MD 9,; Nenan, Soazig MD 10; Omlin, Aurelius MD 11,12,; Buttigliero, Consuelo PhD 13; Delgado Mingorance, Juan Ignacio MD 14; Gonzalez-del-Alba, Aranzazu MD 15,; Delgado, Maria Teresa MD 16; Nole, Franco MD 17; Turco, Fabio MD 1,13,; Pereira Mestre, Ricardo MD 1; Ribi, Karin MD 4,18; Cathomas, Richard MD 5,
doi : 10.1200/JCO.22.01726
Surgeon Quality and Patient Survival After Resection for Non-Small-Cell Lung Cancer.
Ray, Meredith A. PhD 1; Akinbobola, Olawale MPH 2; Fehnel, Carrie BBA 2; Saulsberry, Andrea MBA 2; Dortch, Kourtney BS 2; Wolf, Bradley MD 3; Valaulikar, Ganpat MD 4; Patel, Hetal D. MD 5; Ng, Thomas MD 6; Robbins, Todd MD 7,8; Smeltzer, Matthew P. PhD 1,; Faris, Nicholas R. MDiv 2,8; Osarogiagbon, Raymond U. MBBS, FACP 2,8,,; The Mid-South Quality of Surgical Resection (MS-QSR) Consortium; Wiggins, Horace L. MD; Talton, David MD; Stevenson, Daniel R. MD; Koury, Albert MD
doi : 10.1200/JCO.22.01971
Accumulation of Chronic Disease Among Survivors of Childhood Cancer Predicts Early Mortality.
Esbenshade, Adam J. MD, MSCI 1,2,; Lu, Lu MS 3; Friedman, Debra L. MD, MS 1,2; Oeffinger, Kevin C. MD 4; Armstrong, Gregory T. MD, MSCE 3,; Krull, Kevin R. PhD 3,5,; Neglia, Joseph P. MD, MPH 6; Leisenring, Wendy M. SCD 7; Howell, Rebecca PhD 8,; Partin, Robyn MS 3; Sketch, Amy MS 3; Robison, Leslie L. PhD 3; Ness, Kirsten K. PhD, PT 3
doi : 10.1200/JCO.22.02240
Anthracycline-Free Protocol for Favorable-Risk Childhood ALL: A Noninferiority Comparison Between Malaysia-Singapore ALL 2003 and ALL 2010 Studies.
Ariffin, Hany PhD, MBBS 1,,; Chiew, Edwynn Kean Hui MBBS, CCRP 2; Oh, Bernice Ling Zhi MBBS 2,3; Lee, Shawn Hsien Ren MBBS 2,3; Lim, Evelyn Huizi BSc 2; Kham, Shirley Kow Yin BSc 2; Abdullah, Wan Ariffin MBBS 1; Chan, Lee Lee MBBS 4; Foo, Koon Mian PharmD 5; Lam, Joyce Ching Mei MBBS 5; Chan, Yiong Huak PhD 2; Lin, Hai Peng MBBS 4; Quah, Thuan Chong MBBS 2,3; Tan, Ah Moy MBBS 5; Yeoh, Allen Eng Juh MBBS 2,3,
doi : 10.1200/JCO.22.02347
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.
Virgo, Katherine S. PhD, MBA 1; Rumble, R. Bryan MSc 2; Talcott, James MD, SM 3,
doi : 10.1200/JCO.23.00155
Intent Matters: Real-World Applicability of Idecabtagene Vicleucel Usage in the United States.
Chakraborty, Rajshekhar MD; Al Hadidi, Samer MD
doi : 10.1200/JCO.23.00226
Reply to R. Chakraborty et al.
Hansen, Doris K. MD; Sidana, Surbhi MD; Peres, Lauren C. PhD; Patel, Krina K. MD
doi : 10.1200/JCO.23.00568
